Vaccination of mice for research purpose: Alum is as effective as and safer than complete Freund adjuvant

Reumatismo

Volumn 64, Issue 6, 2012, Pages 380-387

  Bassi, N ^a   Luisetto, R ^a   Ghirardello, A ^a   Gatto, M ^a   Bottazzi, B ^b   Shoenfeld, Y ^c   Punzi, L ^a   Doria, A ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Adjuvants; ASIA syndrome; Glomerulonephritis (GLN); NZB NZWF1 mice; Systemic lupus erythematosus (SLE)

Indexed keywords

ALUMINUM POTASSIUM SULFATE; DOUBLE STRANDED DNA ANTIBODY; FREUND ADJUVANT;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE SYNDROME INDUCED BY ADJUVANT; AUTOINFLAMMATORY DISEASE; BLOOD SAMPLING; CONTROLLED STUDY; IMMUNE RESPONSE; MOUSE; NONHUMAN; PROTEINURIA; SURVIVAL RATE; URINALYSIS;

EID: 84872026447     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: 10.4081/reumatismo.2012.380     Document Type: Article

References (40)

1. Doria A, Zen M, Canova M, et al. SLE diagnosis and treatment: when early is early. Autoimmun Rev. 2010; 10: 55-60.
2. Zandman-Goddard G, Peeva E, Shoenfeld Y. Gender influences SLE-immune cells, genetics, experimental models and lupus patients. Clin Exp Rheumatol. 2010; 28: 297-9.
3. Festing MFW. Inbred strains of mice. Mouse Genome. 1997; 95: 519-686.
4. Ghirardello A, Doria A, Zampieri S, et al. Antinucleosome antibodies in SLE: a two-year follow-up study of 101 patients. J Autoimmunity. 2004; 22: 235-40.
5. Jørgensen MH, Rekvig OP, Jacobsen RS, et al. Circulating levels of chromatin fragments are inversely correlated with anti-dsDNA antibody levels in huwman and murine systemic lupus erythematosus. Immunol Lett. 2011; 138: 179-86.
6. Matrat A, Veysseyre-Balter C, Trolliet P, et al. Simultaneous detection of anti-C1q and antidouble stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares. Lupus. 2011; 20: 28-34.
7. Glück T, Muller-Ladner U. Vaccination in patients with chronic rheumatic or autoimmunediseases. Clin Infect Dis. 2008; 46: 1459-65.
8. Pavlovic M, Kats A, Cavallo M, Shoenfeld Y. Clinical and molecular evidence for association of SLE with parvovirus B19. Lupus. 2010; 19: 783-92.
9. Pender MP. Preventing and curing multiple sclerosis by controlling Epstein-Barr virus infection. Autoimmun Rev. 2009; 8: 563-8.
10. Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y. Adjuvants and autoimmunity. Lupus. 2009; 18: 217-25.
11. Eisenbarth SC, Colegio OR, O'Connor Jr W, et al. Crucial role for the nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature. 2008; 453: 1122-6.
12. Orbach H, Tanay A. Vaccines as trigger for myopathies. Lupus. 2009; 18: 1213-6.
13. Mikaeloff Y, Caridade G, Suissa S, Tardieu M. Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood. Neurology. 2009; 72: 873-80.
14. Di Benedetto G, Pierangeli M, Scalise A, Bertani A. Paraffin oil injection in the body: an obsolete and destructive procedure. Ann Plast Sur. 2002; 49: 391-6.
15. Gherardi RK. Lessons from macrophagic myofasciitis: towards definition of a vaccine adjuvant-related syndrome. Rev Neurolog. 2003; 159: 162-4.
16. Asa PB, Cao Y, Garry RF. Antibodies to squalene in Gulf War syndrome. Exp Mol Pathol. 2000; 68: 55-64.
17. Asa PB, Wilson RB, Garry RF. Antibodies to squalene in recipients of anthrax vaccine. Exp Mol Pathol. 2002; 73: 19-27.
18. Lippi G, Targher G, Franchini M. Vaccination, squalene and anti-squalene antibodies: facts or finction? Eur J Intern Med. 2010; 21: 70-3.
19. Jiang C, Zhao ML, Scearce RM, Diaz M. Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis. Arthritis Rheum. 2011; 63: 1086-96.
20. Jiang C, Zhao ML, Scearce RM, Diaz M. Activation induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis. Arthritis Rheum. 2011; 63: 1086-96.
21. Anderson PN, Potter M. Induction of plasma cell tumours in BALB-c mice with 2, 6, 10, 14-tetramethylpentadecane (pristane). Nature. 1969; 222: 994-5.
22. Satoh M, Reeves WH. Induction on lupusassociated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J Exp Med. 1994; 180: 2341-6.
23. Carlson BC, Jansson AM, Larsson A, et al. The endogenous adjuvant squalene can induce a chronic T-cell-mediated arthritis in rats. Am J Pathol. 2000; 156: 2057-65.
24. Shoenfeld Y, Agmon-Levin N. 'ASIA' Autoimmune/ inflammatory syndrome induced byadjuvants. J Autoimmun. 2011; 36: 4-8.
25. Bassi N, Luisetto R, Del Prete D, et al. Induction of the 'ASIA' syndrome in NZB/NZWF1 mice after injection of complete Freund's adjuvant (CFA). Lupus. 2012; 21: 203-9.
26. Bassi N, Ghirardello A, Blank M, et al. IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus. Ann Rheum Dis. 2010; 69: 1704-10.
27. Bottazzi B, Vouret-Craviari V, Bastone A, et al. Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component. J Biol Chem. 1997; 272: 32817-23.
28. Doria A, Canova M, Tonon M, et al. Infections as triggers and complications of systemic lupus erythematosus. Autoimmun Rev. 2008; 8: 24-8.
29. Doria A, Zampieri S, Sarzi-Puttini P. Exploring the complex relationships between infections and autoimmunity. Autoimmun Rev. 2008; 8: 89-91.
30. Cooke A, Ferraccioli GF, Herrmann M, et al. Induction and protection of autoimmune rheumatic diseases: the role of infections. Clin Exp Rheumatol. 2008; 26: S1-7.
31. Girschick HJ, Guilherme L, Inman RD, et al. Bacterial triggers and rheumatic diseases. Clin Exp Rheumatol. 2008; 26: S12-7.
32. Orbach H, Agmon-Levin N, Zandman-Goddard G. Vaccines and autoimmune diseases of the adult. Discov Med. 2010; 9: 90-7.
33. Geier DA, Geier MR. A case-comtrol study of serious autoimmune adverse avents following hepatitis B immunization. Autoimmunity. 2005; 38: 295-301.
34. Abu-Shakra M. Safety of vaccination of patients with systemic lupus erythematosus. Lupus. 2009; 18: 1205-8.
35. Agmon-Levin N, Paz Z, Israeli E, Shoenfeld Y. Vaccines and autoimmunity. Nat Rev Rheumatol. 2009; 5: 648-52.
36. Wraith DC, Goldman M, Lambert PH. Vaccination and autoimmune disease: what is the evidence? Lancet. 2003; 362: 1659-66.
37. Schattner A. Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines. Vaccine. 2005; 23: 3876-86.
38. Hornung V, Bauernfeind F, Halle A, et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol. 2008; 9: 847-56.
39. Kluger N, Cohen P, Fallet-Bianco C, Guillevin L. Mycobacterium chelonae infection under adalimumab therapy for spondylarthritis. Clin Exp Rheumatol. 2010; 28: 101-2.
40. Gherardi RK, Authier FJ. Macrophagic myofasciitis: characterization and pathophysiology. Lupus. 2012; 21: 184-9.